Ciprofloxacin for methicillin-resistant Staphylococcus aureus infections.
Thirty-seven patients with methicillin-resistant Staphylococcus aureus infections and/or colonization were treated with oral ciprofloxacin (750 mg twice a day). Clinical cure or improvement of infections occurred in 91% of the patients, and bacteriologic cure occurred in 60%. Ciprofloxacin therapy s...
保存先:
| 出版年: | Antimicrob Agents Chemother |
|---|---|
| 主要な著者: | , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
American Society for Microbiology (ASM)
1989
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC171438/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/2712546/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.33.1.128 |
| タグ: |
タグなし, このレコードへの初めてのタグを付けませんか!
|